EUVIMEDEUVIMED entdecken
Crossref

2049-P: Longitudinal Changes in Diabetes Care Delivery Before and During the COVID-19 Pandemic

HENG YEH, ELSA ACEVEDO MARTINEZ, KAMAHL HARRISINGH, QUAN NGUYEN, SUPRIYA SIGDEL, JESSICA GOLDBERG, ANITA SIKHA, CHRISTOPHER CHANG

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-2049-p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von HENG YEH und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: The COVID-19 pandemic disrupted chronic disease management, including diabetes care. While short-term changes in access and monitoring have been reported, long-term shifts in care delivery and metabolic outcomes remain unclear. We evaluated four-year longitudinal changes in diabetes care in a single health care system before and during the COVID-19 pandemic.

Methods

We conducted a retrospective cohort study of adults with diabetes or prediabetes receiving care at a single health system from March 2018 to February 2022. Outcomes included primary care utilization, telemedicine use, adherence to ophthalmology and podiatry screening, medication prescribing patterns, HbA1c, BMI, urinary albumin-creatinine ratio (uACR), and mortality. A COVID-19-positive subgroup was analyzed separately.

Results

Among 2,805 patients, both primary care visits and telemedicine encounters increased significantly during the pandemic, while rates of retinopathy and foot screening declined. Glycemic control remained stable (mean HbA1c 6.9% pre-pandemic vs. 7.0% during pandemic, p=0.343), alongside increased prescribing of SGLT2 inhibitors, GLP-1 receptor agonists, and insulin therapies. In the COVID-19-positive subgroup (n=180), healthcare utilization doubled without significant changes in HbA1c, BMI, or uACR.

Conclusion

Diabetes care delivery underwent sustained changes during the COVID-19 pandemic, marked by expanded telemedicine use, increased primary care engagement, and intensified pharmacologic therapy despite reduced preventive screening. Stable metabolic outcomes suggest that virtual care and medication adjustment partially offset disruptions in in-person services, supporting the role of hybrid care models in chronic disease management. Disclosure H. Yeh: None. E. Acevedo Martinez: None. K. Harrisingh: None. Q. Nguyen: None. S. Sigdel: None. J. Goldberg: None. A. Sikha: None. C. Chang: None.

Zitieren

APA

YEH, H., MARTINEZ, E. A., HARRISINGH, K., NGUYEN, Q., SIGDEL, S., GOLDBERG, J., SIKHA, A., & CHANG, C. (2026). 2049-P: Longitudinal Changes in Diabetes Care Delivery Before and During the COVID-19 Pandemic. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2049-p

Vancouver

YEH H, MARTINEZ EA, HARRISINGH K, NGUYEN Q, SIGDEL S, GOLDBERG J, et al. 2049-P: Longitudinal Changes in Diabetes Care Delivery Before and During the COVID-19 Pandemic. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2049-p

BibTeX
@article{YEH2026,
  author = {YEH, HENG and MARTINEZ, ELSA ACEVEDO and HARRISINGH, KAMAHL and NGUYEN, QUAN and SIGDEL, SUPRIYA and GOLDBERG, JESSICA and SIKHA, ANITA and CHANG, CHRISTOPHER},
  title = {2049-P: Longitudinal Changes in Diabetes Care Delivery Before and During the COVID-19 Pandemic},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-2049-p}
}
Kostenlos starten →